Evidence map›Paper›PMID 28432080›Full record

ArticleThe Journal of cell biology2017

NPM1 directs PIDDosome-dependent caspase-2 activation in the nucleolus.

Kiyohiro Ando, Melissa J Parsons, Richa B Shah, Chloé I Charendoff, Sheré L Paris, Peter H Liu, Sara R Fassio, Brittany A Rohrman, Ruth Thompson, Andrew Oberst and 2 more

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in The Journal of cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Kiyohiro AndoDepartment of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute at Mount Sinai, New York, NY 10029.
Melissa J ParsonsDepartment of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine, Houston, TX 77030.ORCID 0000-0002-2131-9577
Richa B ShahDepartment of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute at Mount Sinai, New York, NY 10029.
Chloé I CharendoffDepartment of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine, Houston, TX 77030.
Sheré L ParisDepartment of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine, Houston, TX 77030.ORCID 0000-0003-1194-4480
Peter H LiuDepartment of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute at Mount Sinai, New York, NY 10029.ORCID 0000-0001-5037-085X
Sara R FassioDepartment of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine, Houston, TX 77030.
Brittany A RohrmanDepartment of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine, Houston, TX 77030.
Ruth ThompsonDepartment of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute at Mount Sinai, New York, NY 10029.
Andrew OberstDepartment of Immunology, University of Washington, Seattle, WA 98109.
Samuel SidiDepartment of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute at Mount Sinai, New York, NY 10029 lxbouchi@txch.org samuel.sidi@mssm.edu.
Lisa Bouchier-HayesDepartment of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine, Houston, TX 77030 lxbouchi@txch.org samuel.sidi@mssm.edu.ORCID 0000-0003-3886-5977
Baylor College of Medicine · USTisch Hospital · USUniversity of Washington · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANTP30CA196521 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Deanna L Benson · 2015 to 2026
$35.4M
Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI RICE, ANDREW P · 1994 to 2015
$21.7M
Hematology Training ProgramT32DK060445 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GOODELL, MARGARET A. · 2002 to 2023
$8.3M
Targeting the Chk1-Suppressed Apoptotic Pathway in HNSCCR01CA178162 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SIDI, SAMUEL · 2013 to 2023
$3.5M
The physiological role of RIPK3-dependent necroptosisR01AI108685 · NIAID · UNIVERSITY OF WASHINGTON · PI OBERST, ANDREW ATWELL · 2014 to 2018
$2.5M
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
Bypassing mutant p53 in radiation therapyF30CA186448 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LIU, HONGDAU PETER · 2014 to 2016
$144k
NCI NIH HHS F30 CA186448NCI NIH HHS P30 CA125123NCI NIH HHS P30 CA196521NCI NIH HHS R01 CA178162NCRR NIH HHS S10 RR024574NIAID NIH HHS P30 AI036211NIAID NIH HHS R01 AI108685NIDDK NIH HHS T32 DK060445
6 · The paper itself

Abstract

The PIDDosome (PIDD-RAIDD-caspase-2 complex) is considered to be the primary signaling platform for caspase-2 activation in response to genotoxic stress. Yet studies of PIDD-deficient mice show that caspase-2 activation can proceed in the absence of PIDD. Here we show that DNA damage induces the assembly of at least two distinct activation platforms for caspase-2: a cytoplasmic platform that is RAIDD dependent but PIDD independent, and a nucleolar platform that requires both PIDD and RAIDD. Furthermore, the nucleolar phosphoprotein nucleophosmin (NPM1) acts as a scaffold for PIDD and is essential for PIDDosome assembly in the nucleolus after DNA damage. Inhibition of NPM1 impairs caspase-2 processing, apoptosis, and caspase-2-dependent inhibition of cell growth, demonstrating that the NPM1-dependent nucleolar PIDDosome is a key initiator of the caspase-2 activation cascade. Thus we have identified the nucleolus as a novel site for caspase-2 activation and function.

Indexed as

ApoptosisDNA DamageAnimalsCaspase 2Cell NucleolusCRADD Signaling Adaptor ProteinCysteine EndopeptidasesDeath Domain Receptor Signaling Adaptor ProteinsEnzyme ActivationGenotypeHEK293 CellsHeLa CellsHumansMice, KnockoutMicroscopy, ConfocalMicroscopy, FluorescenceCASP2 protein, humanCasp2 protein, mouseCaspase 2CRADD protein, humanCRADD Signaling Adaptor ProteinCysteine EndopeptidasesDeath Domain Receptor Signaling Adaptor ProteinsMultiprotein ComplexesNPM1 protein, humanNpm1 protein, mouseNuclear ProteinsNucleophosminPIDD1 protein, humanPidd1 protein, mouseZebrafish Proteins

Identifiers

PMID28432080
PMCPMC5461015
OpenAlexW2605815386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.